SARS-CoV-2 antibody characterization in emergency department, hospitalized and convalescent patients by two semi-quantitative immunoassays
- 1 October 2020
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 509, 117-125
Abstract
No abstract availableKeywords
Funding Information
- Wadsworth Center
- New York State Department of Health
- University of Minnesota
- University of California
This publication has 22 references indexed in Scilit:
- An interactive web-based dashboard to track COVID-19 in real timeThe Lancet Infectious Diseases, 2020
- Evaluation of Enzyme-Linked Immunoassay and Colloidal Gold-Immunochromatographic Assay Kit for Detection of Novel Coronavirus (SARS-Cov-2) Causing an Outbreak of Pneumonia (COVID-19)medRxiv, 2020
- A new coronavirus associated with human respiratory disease in ChinaNature, 2020
- Sex-Specific 99th Percentile Upper Reference Limits for High Sensitivity Cardiac Troponin Assays Derived Using a Universal Sample BankClinical Chemistry, 2020
- Sensitive and Specific Detection of Low-Level Antibody Responses in Mild Middle East Respiratory Syndrome Coronavirus InfectionsEmerging Infectious Diseases, 2019
- Comparative Serological Study for the Prevalence of Anti-MERS Coronavirus Antibodies in High- and Low-Risk Groups in QatarJournal of Immunology Research, 2019
- Utilization of serologic assays to support efficacy of vaccines in nonclinical and clinical trials: Meeting at the CrossroadsVaccine, 2010
- Longitudinal Analysis of Severe Acute Respiratory Syndrome (SARS) Coronavirus-Specific Antibody in SARS PatientsClinical and Vaccine Immunology, 2005
- Immunofluorescence Assay for Serologic Diagnosis of SARSEmerging Infectious Diseases, 2004
- Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory SyndromeScience, 2003